ASENSUS SURGICAL, INC. Quarterly Accumulated Other Comprehensive Income (Loss), Net of Tax in USD from Q3 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
Summary
Asensus Surgical, Inc. quarterly Accumulated Other Comprehensive Income (Loss), Net of Tax history and growth rate from Q3 2015 to Q2 2024.
  • Asensus Surgical, Inc. Accumulated Other Comprehensive Income (Loss), Net of Tax for the quarter ending June 30, 2024 was -$1.27M, a 1.11% decline year-over-year.
Accumulated Other Comprehensive Income (Loss), Net of Tax, Quarterly (USD)
Accumulated Other Comprehensive Income (Loss), Net of Tax, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 -$1.27M -$14K -1.11% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$1.1M +$433K +28.3% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$612K +$1.78M +74.4% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 -$1.83M +$3.06M +62.6% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$1.26M +$2.07M +62.2% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$1.53M -$65K -4.43% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$2.39M -$2.12M -805% Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$4.89M -$5.41M -1044% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$3.32M -$4.83M -321% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 -$1.47M -$2.5M -242% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 -$264K -$3.23M -109% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $518K -$303K -36.9% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $1.5M +$2.78M Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.03M +$3.27M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $2.97M +$4.34M Dec 31, 2020 10-K 2022-02-28
Q3 2020 $821K +$3.86M Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$1.28M -$1.91M -303% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 -$2.24M -$1.63M -267% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 -$1.37M -$2.71M -202% Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$3.04M -$5.42M -228% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $629K -$2.31M -78.6% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 -$611K -$7.95M -108% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $1.34M -$3.69M -73.4% Dec 31, 2018 10-K 2020-03-16
Q3 2018 $2.38M -$1.37M -36.5% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $2.94M +$2.14M +270% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $7.34M +$12M Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $5.03M +$10.8M Dec 31, 2017 10-K 2019-02-27
Q3 2017 $3.75M +$4.71M Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $794K +$2.45M Jun 30, 2017 10-Q 2017-08-02
Q1 2017 -$4.64M -$5.27M -836% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$5.77M -$2.6M -82.2% Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$967K -$538K -125% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 -$1.66M Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $630K Mar 31, 2016 10-Q 2016-05-10
Q4 2015 -$3.17M Dec 31, 2015 10-K 2017-03-06
Q3 2015 -$429K Sep 30, 2015 10-Q 2015-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.